Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Dry Eye > Comparing IPL and LLLT: Which is better for dry eye relief?
  • Dry Eye

Comparing IPL and LLLT: Which is better for dry eye relief?

Kelsey Moroz

Both low-level light therapy (LLLT) and intense pulsed light (IPL) therapy are effective in treating Meibomian gland-related dry eye, but IPL may better improve symptoms and tear film stability compared to LLLT, according to a study.

The quasi-experimental study included 36 patients receiving either IPL (E-Eye machine) or LLLT (Equinox Eye machine) therapy. Each group underwent 3 treatment sessions over 6 weeks, with assessments before the first session and 2 weeks after the final session. Researchers evaluated dry eye symptoms using the Ocular Surface Disease Index (OSDI), non-invasive tear film break-up time (NIBUT), and Meiboscore.

Results showed significant improvement in both groups, with reductions in OSDI scores and Meibomian gland disease severity (P < 0.001), as well as an increase in tear film stability (P < 0.001). However, IPL demonstrated superior efficacy over LLLT in improving all measured parameters.

The study suggests that both IPL and LLLT are effective treatment options for Meibomian gland-related dry eye, with IPL providing better overall outcomes.

Reference
Hassan A, Parveen S, Sameen M, et al. Comparison of Efficacy of Low-Level Light Therapy and Intense Pulsed Light Therapy in Patients with Dry Eyes. J Coll Physicians Surg Pak. 2025;35(3):313-317. doi: 10.29271/jcpsp.2025.03.313. PMID: 40055165.

Share

Related Content

  • Dry Eye

Spotlight on LACRIFILL®

  • Conference Roundup

If your patient has recurrent chalazia, consider co-occurring Demodex blepharitis

  • Conference Roundup

Ocular staining and dry mouth may help identify Sjögren’s-related dry eye

  • Conference Roundup

Daily vaping associated with increased risk of ocular surface disease

  • Conference Roundup

Nearly half of eye care providers show Demodex infestation, with severity increasing over time in practice

  • Conference Roundup

Higher Demodex burden linked to reduced lipid layer thickness in blepharitis

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon